Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 24,918 - -
Change - -49.85% 49.53% -8.95% -16.56% 25.88% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 24,415 23,879 23,460
Change - -51.82% 51.78% -7.74% -18.07% 27.12% -2.19% -1.76%
P/E 54.1x 30.4x 44.7x 49x 40.5x 41.3x 35.9x 32.1x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.96x 6.95x 6.14x
PEG - -2.8x 23.04x -3.2x 27.09x 1.6x 2.4x 2.7x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.38x 6.95x 6.47x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.23x 6.66x 6.09x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 26x 22.9x 20.2x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 32.2x 28.1x 24.6x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 53.7x 43.1x 32.4x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.86% 2.32% 3.09%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9025 0.9729 1.121
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.25% 0.27% 0.32%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.86% 10.2%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,375 3,587 3,854
EBITDA 1 884.7 882.6 827.9 728.2 793.8 940.4 1,041 1,159
EBIT 1 762.4 762 690.6 572.8 622.4 757.5 848.4 952.3
Net income 1 661.8 585.9 593.4 492.7 493.7 614.5 701.2 778
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -1,039 -1,458
Reference price 2 469.01 235.35 352.12 327.56 275.14 354.07 354.07 354.07
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
30.94x4.19x16.22x2.38% 187B
19.75x3.44x12.1x3.41% 112B
17.52x0.2x12.83x0.74% 61.15B
31.31x7.81x19.88x1.27% 54.39B
34.29x3.31x11.52x2.22% 48.17B
33.97x5.97x18.74x-.--% 31.98B
41.66x1.3x11.77x0.16% 30.91B
41.29x7.23x25.96x0.25% 24.92B
25.48x3.87x13.52x1.13% 23.14B
Average 30.69x 4.15x 15.84x 1.29% 63.64B
Weighted average by Cap. 28.62x 3.95x 15.22x 1.89%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WPS Stock
  5. Valuation West Pharmaceutical Services, Inc.